ロード中...
The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB(2), TRPV1, TRPA1 and yet unidentified receptor targets
BACKGROUND: In rheumatoid arthritis (RA), synovial fibroblasts (SF) secrete large amounts of IL-6, IL-8 and matrix metalloproteinases (MMPs) which are crucial for cartilage destruction. RASFs are sensitive to the action of cannabinoids and they not only express cannabinoid receptors type I and II (C...
保存先:
| 出版年: | J Inflamm (Lond) |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4858820/ https://ncbi.nlm.nih.gov/pubmed/27158245 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12950-016-0114-7 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|